Athena Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2M Sell
8,180
-233
-3% -$54.3K 1.04% 20
2025
Q4
$1.74M Sell
8,413
-24
-0.3% -$4.75K 0.89% 21
2025
Q3
$1.56M Sell
8,437
-102
-1% -$17.5K 0.82% 24
2025
Q2
$1.3M Hold
8,539
0.73% 30
2025
Q1
$1.42M Sell
8,539
-20
-0.2% -$3.13K 0.86% 22
2024
Q4
$1.24M Hold
8,559
0.72% 30
2024
Q3
$1.39M Hold
8,559
0.79% 26
2024
Q2
$1.25M Sell
8,559
-10
-0.1% -$1.49K 0.76% 29
2024
Q1
$1.36M Hold
8,569
0.81% 25
2023
Q4
$1.34M Buy
8,569
+40
+0.5% +$6.13K 0.87% 19
2023
Q3
$1.33M Sell
8,529
-643
-7% -$106K 0.95% 21
2023
Q2
$1.52M Sell
9,172
-50
-0.5% -$8.07K 1.04% 17
2023
Q1
$1.43M Buy
9,222
+39
+0.4% +$6.3K 1.03% 19
2022
Q4
$1.62M Buy
9,183
+19
+0.2% +$3.28K 1.19% 14
2022
Q3
$1.5M Sell
9,164
-50
-0.5% -$8.46K 1.26% 15
2022
Q2
$1.64M Buy
9,214
+600
+7% +$107K 1.29% 14
2022
Q1
$1.53M Buy
+8,614
New +$1.47M 1.19% 15

Other funds holding JNJ

Athena Investment Management's JNJ Position: Q1 2026 in Review

Athena Investment Management reduced its Johnson & Johnson (JNJ) stake by 2.8% in Q1 2026, selling an estimated $54.3K and leaving 8,180 shares worth $2M. The position accounts for 1.04% of the portfolio, ranked #20.

Athena Investment Management first reported a position in JNJ in Q1 2022 and has held it in 17 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Athena Investment Management held 8,180 shares of Johnson & Johnson worth $2M as of Q1 2026.
  • Athena Investment Management sold 233 Johnson & Johnson shares in Q1 2026, an estimated $54.3K.
  • Johnson & Johnson made up 1.04% of Athena Investment Management's portfolio in Q1 2026, its #20 holding.
  • Athena Investment Management first reported a position in Johnson & Johnson in Q1 2022 and has held it in 17 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Athena Investment Management's 13F filing for Q1 2026, filed 12 May 2026.